PME PRO MEDICUS LIMITED Stock Forecast Outlook:Negative Period (n+30) 14 Sep 2020


Stock Forecast


As of Mon Sep 14 2020 23:11:11 GMT+0000 (Coordinated Universal Time) shares of PME PRO MEDICUS LIMITED -1.49 percentage change in price since the previous day's close. Around 481400 of 104211574 changed hand on the market. The Stock opened at 26.39 with high and low of 25.43 and 26.86 respectively. The price/earnings ratio is: 117.11 and earning per share is 0.22. The stock quoted a 52 week high and low of 14.5 and 32.14 respectively.

BOSTON (AI Forecast Terminal) Mon, Sep 14, '20 AI Forecast today took the forecast actions: In the context of stock price realization of PME PRO MEDICUS LIMITED is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+30) for PME PRO MEDICUS LIMITED as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of PME PRO MEDICUS LIMITED as below:

PME PRO MEDICUS LIMITED Credit Rating Overview


We rerate PME PRO MEDICUS LIMITED because explicitly excluded by regulation from those liabilities that may be bailed in if the obligor enters a bail-in resolution. We use econometric methods for period (n+30) simulate with Volume + Moving Average Pearson Correlation. Reference code is: 3138. Beta DRL value REG 30 Rational Demand Factor LD 4582.871999999999. We believe that when a company is viewed as being on the cusp between two liquidity descriptors and has higher-than-average cash plus inventory/unadjusted debt compared with similarly constituted peers, that helps support the better liquidity assessment. However, in the case of a nonresidential developer, given that its inventory is typically less liquid (and the greater potential for inventory to suffer value erosion in a downturn), we do not consider this measure as pertinent. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for PME PRO MEDICUS LIMITED as below:
Frequently Asked QuestionsQ: What is PME PRO MEDICUS LIMITED stock symbol?
A: PME PRO MEDICUS LIMITED stock referred as ASX:PME
Q: What is PME PRO MEDICUS LIMITED stock price?
A: On share of PME PRO MEDICUS LIMITED stock can currently be purchased for approximately 25.87
Q: Do analysts recommend investors buy shares of PME PRO MEDICUS LIMITED ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for PME PRO MEDICUS LIMITED at daily forecast section
Q: What is the earning per share of PME PRO MEDICUS LIMITED ?
A: The earning per share of PME PRO MEDICUS LIMITED is 0.22
Q: What is the market capitalization of PME PRO MEDICUS LIMITED ?
A: The market capitalization of PME PRO MEDICUS LIMITED is 2695953506
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com